Company Shanghai Fudan Forward S&T Co., Ltd

Company Shanghai Fudan Forward S&T Co., Ltd

600624

CNE0000006S1

Pharmaceuticals

Equities

600624

CNE0000006S1

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-07 pm EDT			5-day change	1st Jan Change
4.19 ^CNY	-0.48%		+1.95%	-26.62%

Apr. 29	Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 29	Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

SHANGHAI FUDAN FORWARD S&T CO., LTD is a China-based company, principally engaged in the manufacture and distribution of pharmaceuticals. The Company's pharmaceuticals include digestive system drugs, nervous system drugs, antineoplastic drugs, circulatory drugs, immune function medications and others. The Company is also engaged in the provision of financial insurance software products. It distributes its products within domestic markets and to overseas markets.

Number of employees: 1,426

CNY in Million	2021	Weight	2022	Weight	Delta
Digestive System Medicines 33.3 %	285	31.2 %	222	33.3 %	-21.94%
Financial Insurance System Software 30.6 %	233	25.5 %	204	30.6 %	-12.68%
Nervous System Drugs 13.3 %	89	9.7 %	89	13.3 %	+0.01%
Fuhua Park Haimen Garden Supporting Residential Project (Fuhua Wenyuan) 7.7 %	181	19.8 %	51	7.7 %	-71.59%
Circulatory System Drugs 5.0 %	37	4.0 %	34	5.0 %	-8.93%
Anti-tumor Drugs 3.7 %	46	5.0 %	25	3.7 %	-46.41%
Immune Function Regulating Drugs 2.9 %	21	2.3 %	19	2.9 %	-6.63%
Other Business 1.9 %	14	1.6 %	13	1.9 %	-10.92%
Other Medicines 1.5 %	8	0.9 %	10	1.5 %	+27.43%

CNY in Million	2021	Weight	2022	Weight	Delta
China 65.0 %	731	70.2 %	513	65.0 %	-29.84%
Overseas 35.0 %	310	29.8 %	276	35.0 %	-11.02%

Managers	Title	Age	Since
Zhi Bin Yu IRC	Investor Relations Contact	-	-
Yue Zhuang PRN	Corporate Officer/Principal	40	20-12-07
Min Shen SEC	Corporate Secretary	46	00-12-31

Members of the board	Title	Age	Since
Wei Qian BRD	Director/Board Member	61	20-12-07
Yue Zhuang PRN	Corporate Officer/Principal	40	20-12-07
Yan Lu BRD	Director/Board Member	43	20-12-07
Lei Gang Weng CHM	Chairman	48	20-12-07
Zhong Ming Jiang BRD	Director/Board Member	42	20-12-07
Xin Wei Jiang BRD	Director/Board Member	39	Dec. 06
Hai Yan Qiang BRD	Director/Board Member	44	Dec. 06
Qian Qian Ding BRD	Director/Board Member	31	Dec. 06

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	684,712,010	449,197,226 ( 65.60 %)	5,365,068 ( 0.7836 %)	65.60 %

Name	Equities	%	Valuation
Da Cheng Fund Management Co., Ltd. 0.0661 %	452,626	0.0661 %	288 707 ¥
Truvalue Asset Management Co. Ltd. 0.000204 %	1,400	0.000204 %	893 ¥

Shanghai Fudan Forward S&T Co., Ltd.

525 Guoquan Road

200433, Shanghai

http://www.forwardgroup.com

address Shanghai Fudan Forward S&T Co., Ltd(600624)

	1st Jan change	Capi.
SHANGHAI FUDAN FORWARD S&T CO., LTD	-26.62%	396M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.83%	43.57B
OTSUKA HOLDINGS CO., LTD.	+21.21%	22.7B
SANDOZ GROUP AG	+16.41%	14.32B
CIPLA LIMITED	+11.11%	13.42B
ZYDUS LIFESCIENCES LIMITED	+45.91%	11.83B
ONO PHARMACEUTICAL CO., LTD.	-6.86%	6.98B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.41%	5.51B

Generic Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Generic Pharmaceuticals